Other Events ·
Kyverna Therapeutics, Inc. entered into a Clinical and Commercial Supply Agreement with ElevateBio Basecamp, Inc. on…
KYTXKyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. entered into a Clinical and Commercial Supply Agreement with ElevateBio Basecamp, Inc. on July 23, 2026, replacing a prior development and manufacturing services agreement. The agreement provides for the clinical and commercial supply of the company's lead product candidate, mivocabtagene autoleucel (miv-cel), to support potential U.S. commercial and global clinical supply. Kyverna is a biopharmaceutical company developing cell therapies for autoimmune diseases.